In today’s evolving healthcare and regulatory landscape, clinical trial success demands more than just data—it requires strategic insight. Our Clinical Trial Analysis Services provide data-driven precision combined with regulatory acumen, helping you navigate complex research environments confidently. We go beyond surface-level analysis to uncover actionable insights that accelerate progress, improve outcomes, and anticipate future opportunities in clinical research. Whether you’re optimizing trial design, understanding trial outcomes, or mapping global research trends, we serve as your analytical partner—ensuring your research is informed, impactful, and aligned with the highest scientific standards.
Review case studies that showcase how our clinical trial analysis services have empowered sponsors, CROs, and research teams to make faster, more informed, and strategically aligned decisions. Our deep-dive analytics and regulatory expertise help transform complex trial data into clear, actionable insights that move research forward more intelligently and efficiently.
Wissen supported a global pharmaceutical company in evaluating the commercial viability of introducing a new formulation of Ruxolitinib (free base) by analyzing clinical trial trends and conducting a comprehensive patent landscape search. The study focused on identifying geographic white spaces across Asia and the Middle East, evaluating existing phosphate-based formulations, and understanding the therapeutic directions of ongoing research.
Wissen supported a global pharmaceutical company in evaluating the commercial viability of introducing a new formulation of Ruxolitinib (free base) by analyzing clinical trial trends and conducting a comprehensive patent landscape search. The study focused on identifying geographic white spaces across Asia and the Middle East, evaluating existing phosphate-based formulations, and understanding the therapeutic directions of ongoing research.
We offered a comprehensive clinical intelligence landscape of G-protein-coupled receptor (GPCR) targeting drugs that are in clinical development or have reached the launch stage. It focuses on analysing the scientific reasons behind clinical trial failures, with particular attention to safety issues and efficacy concerns across different trial phases.
Structuring clinical trial information into clear, searchable categories for better decision-making.
Procuring data from global registries like ClinicalTrials.gov, EU-CTR, and more.
Identifying the most relevant trials using public and proprietary databases, government sources, and CRO intelligence.
Filtering out noise to focus on the most relevant trials and therapeutic developments.
Creating comprehensive trial summaries with sponsor, phase, indication, outcomes, and more
Mining results and efficacy endpoints from scientific literature and trial databases
Presenting trends, gaps, and opportunities through visual tools like graphs, charts, and dashboards
Strategic Insights Across the Development Lifecycle: From preclinical to Phase IV and commercialization, we offer end-to-end analysis—including terminated, ongoing, and completed trials.
Sponsor & CRO Intelligence: Deep visibility into trial sponsors, funding sources, and key stakeholders shaping the landscape.
Phase-Wise Analysis: Understand success rates, hurdles, and pipeline progression across trial phases.
Recruitment & Operational Insights: Evaluate recruitment strategies, timelines, and geographic diversity to fine-tune site selection and planning.
Global Perspective: Geographical mapping of trials, regulatory environments, and patient demographics to support regional strategy formulation.
We go the extra mile to protect your
innovations.
Count on our vetted IP and Patent attorneys to provide expert guidance and assistance in addressing your legal queries.
